See also this year's filing and all EDGAR filings for this company.
PDF Report 0001662244_2023_Cyteir_Therapeutics_Inc.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001662244, Cyteir Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 149,209,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,699,000 |
| 3 | remainder_Assets | 2,324,000 |
| 4 | LiabilitiesCurrent | 5,315,000 |
| 5 | LiabilitiesNoncurrent | 1,631,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,546,000 |
| 9 | ResearchAndDevelopmentExpense | 34,624,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 2,109,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 153,232,000 |
| 1 | Liabilities | 6,946,000 |
| 2 | Expenses | 48,170,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 146,286,000 |
| 5 | NetIncome | -46,061,000 |
| 6 | ComprehensiveNetIncome | -46,061,000 |
| 7 | BaseVar | 105,228,500 |
| 8 | EconomicCapitalRatio | 2.57 |
Edgar->Model Mapping
Feature Distribution
Change over Time
